Wall Street Pressured by Economic Weakness and Investigations
Wall Street indices face declines as U.S. economic data shows weakness, affected by tariffs and spending cuts. UnitedHealth's stock drops due to Justice Department investigation, impacting healthcare shares. Market jitters rise from economic slowdown signs, Trump's tariff threats, and Federal Reserve uncertainty.
On Friday, Wall Street experienced a downturn as economic data revealed vulnerabilities in the American economy. The situation was exacerbated by UnitedHealth's stock plummeting after reports emerged about a Justice Department investigation into the company's Medicare billing practices.
S&P Global's data indicated a stagnation in U.S. business activity due to concerns over tariffs and government expenditure cuts. Chris Williamson of S&P Global noted widespread anxiety among companies about federal policies impacting the market.
The Dow Jones Transport Average had its worst day this year, dropping 2.4%. Health insurers like CVS Health and Humana also saw declines, while the broader market faced pressure from President Trump's tariff threats and uncertain Federal Reserve policies.
ALSO READ
-
Venezuelan Central Bank's Gold Transfer Nears Completion
-
Global Shares Surge Amidst Central Bank Rate Decisions
-
Wall Street Rebounds as Oil and Interest Rates Stabilize
-
Wall Street's Resurgence: Market Gains Amid Easing Pressures
-
Wall Street's Resurgence: Tech Rally and Eased Oil Woes Drive Market Recovery
Google News